Edition:
India

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

815.40INR
15 Jan 2018
Change (% chg)

-- (--)
Prev Close
Rs815.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
546,197
52-wk High
Rs1,274.70
52-wk Low
Rs752.30

Chart for

About

Strides Shasun Limited, formerly Strides Arcolab Limited, is a vertically integrated global pharmaceutical company. The Company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and formulations, as well as biotech. Its business segments include Pharmaceutical and Biotech businesses. Its... (more)

Overall

Beta: 0.59
Market Cap(Mil.): Rs74,972.77
Shares Outstanding(Mil.): 89.49
Dividend: 4.50
Yield (%): 0.54

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.44
EPS (TTM): -- -- --
ROI: -- 14.85 10.61
ROE: -- 16.31 14.21

RPT-ICRA ratings for Indian debt instruments-Jan 3

(Repeating to add more ratings) Jan 3 Below are the ratings awarded by Investment Information Credit Rating Agency Ltd. (ICRA) for local debt instruments as of January 2, 2018. COMPANY INSTRUMENT RATING AMOUNT MOVEMENT (RS.MLN) ------ ---------- ------ ----- --------- SHORT TERM RATINGS: ----------------

04 Jan 2018

BRIEF-Sequent Scientific Gets Shareholders' Nod For Scheme Of Arrangement with Strides Shasun

* GETS SHAREHOLDERS' NOD TO APPROVE SCHEME OF ARRANGEMENT BETWEEN STRIDES SHASUN, CO AND SOLARA ACTIVE PHARMA SCIENCES Source text: (http://bit.ly/2DoTPO4) Further company coverage:

28 Dec 2017

BRIEF-Strides Shasun Gets Shareholders' Nod For Composite Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences

* GETS SHAREHOLDERS' NOD FOR COMPOSITE SCHEME OF ARRANGEMENT BETWEEN CO, SEQUENT SCIENTIFIC AND SOLARA ACTIVE PHARMA SCIENCES Source text - http://bit.ly/2pNrrDh Further company coverage:

28 Dec 2017

BRIEF-Strides Shasun Acquires Controlling Stake In Trinity Pharma

* SAYS ACQUIRES CONTROLLING STAKE IN TRINITY PHARMA, SOUTH AFRICA

20 Dec 2017

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage:

04 Dec 2017

BRIEF-Strides Shasun gets U.S. FDA approval for acetazolamide tablets​

* Says product to be marketed by Strides Pharma Inc in the US market‍​ Source text for Eikon: Further company coverage:

22 Nov 2017

BUZZ-Strides, Eris rise on deal for India brand business

** Strides Shasun Ltd rises as much as 4.5 pct to its highest in almost a fortnight

20 Nov 2017

BRIEF-Strides Shasun approves scheme of amalgamation for merger of units with co‍​

* Says approved scheme of amalgamation for merger of units Arrow Remedies, Fagris Medica, Strides Chemicals with co‍​ Source text - http://bit.ly/2A2odNz Further company coverage:

31 Oct 2017

BRIEF-India's Strides Shasun Sept-qtr consol profit down 87 pct

* Sept quarter consol net profit 107.3 million rupees versus profit of 854.3 million rupees last year

31 Oct 2017

BRIEF-Strides Shasun gets U.S. FDA approval for omega-3-acid ethyl esters capsules

* Says Strides Shasun receives USFDA approval for omega-3-acid ethyl esters capsules

20 Sep 2017

Earnings vs. Estimates